New hope for ALK+ lung cancer: Real-World study of lorlatinib launches
NCT ID NCT06487078
First seen Apr 05, 2026 · Last updated May 22, 2026 · Updated 11 times
Summary
This study tracks how effective and safe the drug lorlatinib is for people with advanced ALK-positive non-small cell lung cancer who have not had treatment before. Researchers will follow about 90 patients in France to see how long they live without the cancer growing and their overall survival. The goal is to understand how well the drug works in everyday medical practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALK+ NON-SMALL-CELL LUNG CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CH ALBI
RECRUITINGAlbi, 81000, France
-
CHBA
RECRUITINGVannes, 56017, France
-
CHIC
RECRUITINGCréteil, 94010, France
-
CHRU Bretonneau
RECRUITINGTours, 37000, France
-
CHRU de Nancy
NOT_YET_RECRUITINGNancy, 54035, France
-
CHU Nantes
RECRUITINGNantes, 44093, France
-
Centre Hospitalier Francois Mitterand
RECRUITINGPau, 64046, France
-
Centre Hospitalier du Pays d AIX
RECRUITINGAix-en-Provence, 13100, France
-
Centre Leon Berard
NOT_YET_RECRUITINGLyon, 69373, France
-
Ch Annecy Genevois
RECRUITINGPringy, 74374, France
-
Ch Avignon
NOT_YET_RECRUITINGAvignon, 84000, France
-
Ch Cornouaille
RECRUITINGQuimper, 29107, France
-
Ch Troyes
RECRUITINGTroyes, 10003, France
-
Chits Ch Sainte Musse
NOT_YET_RECRUITINGToulon, 83000, France
-
Chu Amiens Sud
RECRUITINGAmiens, 80000, France
-
Chu Limoges
RECRUITINGLimoges, 87042, France
-
Clcc Georges Francois Leclerc
RECRUITINGDijon, 21000, France
-
Clinique Teissier
RECRUITINGValenciennes, 59300, France
-
Hopital Cochin
NOT_YET_RECRUITINGParis, 75014, France
-
Hopital Europeen Georges Pompidou
RECRUITINGParis, 75908, France
-
Hopital Foch
RECRUITINGSuresnes, 92151, France
-
Hopital Morvan
NOT_YET_RECRUITINGBrest, 29000, France
-
Hopital Pontchaillou
RECRUITINGRennes, 35033, France
-
Hopital Robert Schuman de Vantoux
RECRUITINGMetz, 57070, France
-
Hopital Saint Joseph
RECRUITINGParis, 75674, France
-
Hopital de Rangueil
RECRUITINGTSA 50032 Toulouse, 31059, France
-
Hopital de Villefranche Sur Saone
NOT_YET_RECRUITINGGleizé, 69400, France
-
Institut Bergonie
NOT_YET_RECRUITINGBordeaux, 33076, France
-
Institut Curie
RECRUITINGParis, Paris, 75005, France
-
Institut Godinot
RECRUITINGReims, 51056, France
-
Polyclinique Bordeaux Nord Aquitaine
NOT_YET_RECRUITINGBordeaux, 30072, France
Conditions
Explore the condition pages connected to this study.